Delivery Order SPE2DB24D2100-SPE2DB24FBDTK

Award Date 9/27/24
Potential Completion Date 10/21/24
Potential Value $2.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,271.36, is for the delivery of 4,568,078,577 units of the prescription medication YONSA 125 MG TABLET 120S. The contract is a firm fixed-price, non-set-aside award with a performance period ending on May 20, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The $4,390.96 firm-fixed-price contract is for the delivery of 4,564,298,023 units of the drug YONSA 125 MG TABLET 120S. The contract has a completion date of May 7, 2024. Amerisourcebergen holds a broader $999,999,999.00 Indefinite Delivery Contract with DLA Troop Support Medical to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office division. The contract, valued at $2,195.48, is for the supply of YONSA 125 MG TABLET 120S, a pharmaceutical product. The contract is a firm fixed-price, with an ultimate completion date of August 13, 2024. The contract does not have a set-aside designation. AmerisourceBergen Drug Corp is a major supplier of pharmaceutical products and medical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,566,294,927 units of the drug YONSA (125 mg tablets, 120 count). The $2,195.48 firm fixed-price contract has a period of performance through November 2024. The delivery order falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $4,390.96 contract is for the supply of 4,564,133,768 units of the pharmaceutical product YONSA 125 MG TABLET 120S. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,271.36, is for the delivery of YONSA 125 MG TABLET 120S, a pharmaceutical product. The contract has an ultimate completion date of January 6, 2025 and is a firm fixed-price arrangement. There is no set-aside designation indicated for this contract. AmerisourceBergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,271.36 firm fixed-price delivery order is for the supply of 4,568,141,590 units of the pharmaceutical product YONSA 125 MG TABLET 120S. The contract has an ultimate completion date of May 27, 2025. This award is not designated as a set-aside and was competed openly. AmerisourceBergen Drug Corp holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the drug YONSA 125 MG TABLET 120S. The contract has a ceiling value of $2,195.48 and a period of performance through July 9, 2024. It is a firm fixed-price contract, classified as a delivery order and not designated with any set-aside requirements. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,542.74, is for the delivery of YONSA 125 MG TABLET 120S, a pharmaceutical product. The contract is a firm fixed-price delivery order with an ultimate completion date of June 2, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,271.36 firm fixed-price delivery order is for the supply of YONSA 125 MG TABLET 120S, a pharmaceutical product. The contract has an ultimate completion date of June 26, 2025 and is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract...
  • SPE2DB24D2100
    Indefinite Delivery Contract
  • SPE2DB24D2100-SPE2DB24FBDTK
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $2,195.48 firm-fixed-price contract is for the delivery of 4,565,965,358 units of YONSA 125 MG Tablet 120S, a pharmaceutical product. The contract has an ultimate completion date of October 21, 2024. AmerisourceBergen is a major pharmaceutical distributor that supplies a wide range of medical products and drugs to various government agencies and healthcare programs, including military treatment facilities and veterans' hospitals. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which allows the government to efficiently procure essential pharmaceutical and medical supplies from the company. There is no set-aside designation associated with this contract award.

Generated 12/27/24, 9:24 AM